These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20828268)

  • 1. Almotriptan for the acute treatment of adolescent migraine.
    Lewis DW
    Expert Opin Pharmacother; 2010 Oct; 11(14):2431-6. PubMed ID: 20828268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
    Berenson F; Vasconcellos E; Pakalnis A; Mao L; Biondi DM; Armstrong RB
    Headache; 2010 May; 50(5):795-807. PubMed ID: 20546320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Almotriptan efficacy in migraine with allodynia: a rebuttal to Burstein and Jakubowski's critique of Schoenen et al.
    Schoenen J; Vandenheede M
    Cephalalgia; 2010 Sep; 30(9):1147-8. PubMed ID: 20713568
    [No Abstract]   [Full Text] [Related]  

  • 4. Spotlight on eletriptan in migraine.
    McCormack PL; Keating GM
    CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study.
    Lanteri-Minet M; Díaz-Insa S; Leone M; Vila C; Clissold SP;
    Int J Clin Pract; 2010 Jun; 64(7):936-43. PubMed ID: 20584227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Triptans in migraine--here and now (15 years after they were implemented in therapy)].
    Prusiński A; Rozniecki JJ
    Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of almotriptan in triptan-experienced and triptan-naïve patients.
    Pascual J; Diener HC
    Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.
    Leone M; Vila C; McGown C
    Expert Rev Neurother; 2010 Sep; 10(9):1399-408. PubMed ID: 20819011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Almotriptan for the treatment of acute migraine: a review of early intervention trials.
    Antonaci F; De Cillis I; Cuzzoni MG; Allena M
    Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study.
    Massiou H; Pradalier A; Donnet A; Lanteri-Minet M; Allaf B
    Eur Neurol; 2006; 55(4):198-203. PubMed ID: 16772716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
    Sandrini G; Dahlöf CG; Mathew N; Nappi G
    Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine in the triptan era: progresses achieved, lessons learned and future developments.
    Bigal ME; Krymchantowski AV; Ho T
    Arq Neuropsiquiatr; 2009 Jun; 67(2B):559-69. PubMed ID: 19623468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of frovatriptan.
    Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almotriptan: an effective and well-tolerated treatment for migraine pain.
    Pascual J
    Drugs Today (Barc); 2003; 39 Suppl D():31-6. PubMed ID: 15071618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
    Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
    Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almotriptan: a review of 20 years' clinical experience.
    Pascual J; Vila C
    Expert Rev Neurother; 2019 Aug; 19(8):759-768. PubMed ID: 30845850
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral almotriptan: practical uses in the acute treatment of migraine.
    Dowson AJ
    Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.